Ranbaxy Laboratories Ltd has informed the Exchange regarding a press release dated September 06, 2007, titled "Ranbaxy Gains US FDA Approval to Manufacture and Market Carvedilol Tablets in the US Market; A Blockbuster Brand that will be Commercialized as an Affordable Generic".
No comments:
Post a Comment